Romeo, M <br/><br/>
Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients.  [electronic resource] 

 -  European journal of neurology  Jul 2013 
 - 1060-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1468-1331 
<br/><br/><label>Standard No.: </label>10.1111/ene.12119  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Adolescent<br/>Adult<br/>Aged<br/>Drug Resistance<br/>Female<br/>Glatiramer Acetate<br/>Humans<br/>Interferon-beta--therapeutic use<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Neuroimaging<br/>Peptides--therapeutic use<br/>Retrospective Studies<br/>Risk Factors<br/>Secondary Prevention<br/>Treatment Outcome